CYP 2C93 variant is associated with antidiabetes efficacy of gliclazide in Chinese type 2 diabetes patients-Reference-Cited by-同舟云学术

CYP 2C93 variant is associated with antidiabetes efficacy of gliclazide in Chinese type 2 diabetes patients

Published:2016-03-08 Issue:5 Volume:7 Page:764-768
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Investig

Author:

Zeng Wotan¹,Guo Yali²,Chen Peixian³,Liu Zhike⁴,Chen Dafang⁴,Han Chunji⁵

Affiliation:

1. Department of Physiology and Pathophysiology College of Medicine Yanbian University Yanji Jilin Province China

2. Department of Endocrinology Central Hospital of Shenzhen Guangming New District Shenzhen China

3. Medical College Shantou Guangdong Province China

4. Department of Epidemiology and Biostatistics School of Public Health Peking University Health Science Center Beijing China

5. Department of Immunology and Pathogenic Biology College of Medicine Yanbian University Yanji Jilin Province China

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.12486

Reference32 articles.

1. Sulfonylurea pharmacogenomics in Type 2 diabetes: the influence of drug target and diabetes risk polymorphisms

2. The Role of Sulphonylureas in the Management of Type 2 Diabetes Mellitus

3. Sulfonylurea receptor ‐1 (SUR1): genetic and metabolic evidences for a role in the susceptibility to type 2 diabetes mellitus;Reis AF;Diabetes Metab,2002

4. Effect of Genetic Polymorphisms in Cytochrome P450 (CYP) 2C9 and CYP2C8 on the Pharmacokinetics of Oral Antidiabetic Drugs

5. Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes*

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy subjects;Archives of Pharmacal Research;2023-04-25

2. Identification and in vitro functional assessment of 10 CYP2C9 variants found in Chinese Han subjects;Frontiers in Endocrinology;2023-03-15

3. Pharmacogenetic Algorithms;Pharmacogenomics in Clinical Practice;2023

4. Pharmacogenomics of sulfonylureas in type 2 diabetes mellitus; a systematic review;Journal of Diabetes & Metabolic Disorders;2021-12-01

5. A pharmacogenetic pilot study of CYP2C9 common genetic variant and sulfonylureas therapeutic response in type 2 diabetes mellitus patients;Journal of Diabetes & Metabolic Disorders;2021-09-14